Kayt Sukel

More consumers are purchasing short-term limited duration insurance plans-which will likely have long-lasting effects to consumers and the insurance market as a whole.

A new ruling on the ACA adds more uncertainty about the law’s future.

A recent study suggests healthcare organizations see reimbursement concerns-as well as differences in business culture – as roadblocks to embracing digital health partnerships.

Could per-person adjustments to Medicaid payments help better address social inequalities that affect overall health?

CMS has put forth pricing transparency provisions for both hospitals and insurers – but what will they really mean for healthcare?

As more healthcare organizations look to curb hospital readmission rates, they are taking a hard look at one of medicine’s most complex conditions-cancer.

Healthcare is still undergoing a large number of M&As – but are they offering the kind of value originally sought? New research suggests not.

How can payers appropriately plan and manage benefit coverage with so many expensive specialty drugs coming down the pipeline?

As more biosimilar drugs gain approval, managed care organizations need to consider how to best utilize them for optimal savings.

As more of the healthcare industry moves to value-based contracts, it is imperative that managed care organizations can successfully measure outcomes.

With the proposed rebate rule now withdrawn, what will Congress do to help curb drug spend?

As digital health and therapeutic capabilities continue to grow, it is vital that managed care organizations keep one eye toward the future.

At AMCP Nexus 2019, experts weigh in on new and emerging specialty medications.

As more healthcare organizations and private equity firms purchase or invest in physician groups, costs for consumers rise.

A new survey suggests that healthcare organizations are missing the vital claims data they need to fully embrace risk-based payment arrangements.

A new survey suggests that more states-and payer organizations-are expanding telehealth coverage.

Will a new final rule expanding the use of health reimbursement arrangements shake up the markets as much as some fear?

With a rapidly-growing employment environment, how can healthcare orgs best recruit and retain the right employees?

How can healthcare organizations better overcome the challenges involved with integrating social determinants of health data into their population health initiatives?

Why the introduction of telehealth kiosks in employers is part of a trend of increased patient visibility.

The number of members joining Health Care Sharing Ministries are swelling. One reason may be that consumers don’t understand such organizations don’t provide actual health insurance.

With a record number of innovative drugs queued for FDA approval, managed healthcare executives have an eye toward innovative new products that tackle difficult conditions.

With a country-wide focus on reducing the cost of prescription drugs, managed healthcare executives make their forecasts concerning the future of list prices.

The Trump Administration is calling for better price transparency to help control healthcare costs-but is publishing list prices enough?

How the right benefit design can help increase patient engagement and adherence to key maintenance therapies.

The rare disease community struggles to balance care with costs.

With the future of the ACA still in question, new studies suggest its provision for Medicaid expansion has helped to correct healthcare disparities in cancer.

Managed Healthcare Executive’s Managed Care Pharmacy Survey identifies different ways specialty pharmacy stakeholders believe they can reduce industry costs moving forward.

How will payers, providers, and patients respond when a $2 million drug drops into the market?

A new RAND study uncovers significant differences between healthcare costs paid by privately insured patients and those paid out by Medicare.